Refine
Year of publication
Document Type
- Article (21)
Has Fulltext
- yes (21)
Is part of the Bibliography
- no (21)
Keywords
- TAVI (4)
- aortic stenosis (3)
- Aortic stenosis (2)
- Heart failure (2)
- MitraClip (2)
- Aortic valve (1)
- Aortic valve replacement (1)
- CT (1)
- Cerebral oxygen saturation (1)
- Chronic heart failure (1)
- Coronary artery disease (1)
- Critical care (1)
- Extracorporeal membrane oxygenation (1)
- Fibroblast growth factor (1)
- Functional mitral regurgitation (1)
- Impella (1)
- In-hospital cardiac arrest (1)
- Inflammation (1)
- Kidney transplant recipients (1)
- MAGGIC score (1)
- Monocytes (1)
- Myocardial revascularization (1)
- Myocarditis (1)
- NIRS (1)
- Outcome (1)
- Percutaneous coronary intervention (1)
- Pulmonary artery pressure (1)
- Remote monitoring (1)
- Risk prediction (1)
- SARS-COV-2 (1)
- Seattle heart failure model (1)
- T cells (1)
- TAPSE (1)
- Transcatheter based aortic valve implantation (1)
- Valvular cardiomyopathy (1)
- acute kidney injury (1)
- algorithm (1)
- anemia (1)
- biomarker (1)
- comorbidity (1)
- complications (1)
- computed tomography (1)
- coronary artery disease (1)
- critical care unit (1)
- critical ill patients (1)
- decision tree (1)
- delirium (1)
- endothelial function (1)
- erythropoietin (EPO) (1)
- hemodialysis (1)
- hospital length of stay (1)
- low-risk (1)
- patient-reported outcomes (1)
- prediction (1)
- prognosis (1)
- prognostic value (1)
- sepsis (1)
- stroke (1)
- transcatheter aortic valve replacement (TAVR) (1)
- transcatheter aortic valve replacement (TAVR), aortic valve stenosis (AS) (1)
- von Willebrand disease (1)
Institute
Background: The aim of this study was to identify pre-operative parameters able to predict length of stay (LoS) based on clinical data and patient-reported outcome measures (PROMs) from a scorecard database in patients with significant aortic stenosis who underwent TAVI (transfemoral aortic valve implantation). Methods: 302 participants (51.7% males, age range 78.2–84.2 years.) were prospectively recruited. After computing the median LoS value (=6 days, range = 5–8 days), we implemented a decision tree algorithm by setting dichotomized values at median LoS as the dependent variable and assessed baseline clinical variables and PROMs (Clinical Frailty Scale (CFS), EuroQol-5 Dimension-5 Levels (EQ-5D) and Kansas City Cardiomyopathy Questionnaire (KCCQ)) as potential predictors. Results: Among clinical parameters, only peripheral arterial disease (p = 0.029, HR = 1.826) and glomerular filtration rate (GFR, cut-off < 33 mL/min/1.73 m2, p = 0.003, HR = 2.252) were predictive of LoS. Additionally, two PROMs (CFS; cut-off = 3, p < 0.001, HR = 1.324 and KCCQ; cut-off = 30, p = 0.003, HR = 2.274) were strong predictors. Further, a risk score for LoS (RS_LoS) was calculated based on these predictors. Patients with RS_LoS = 0 had a median LoS of 5 days; patients RS_LoS ≥ 3 had a median LoS of 8 days. Conclusions: based on the pre-operative values of the above four predictors, a personalized prediction of LoS after TAVI can be achieved.